Ming Yeung/Getty Images
- Apple must stop selling its Series 9 and Ultra 2 watches with blood oxygen monitoring functionality.
- Apple has been in an ongoing patent dispute with medtech company Masimo over the feature.
- A US court denied Apple's request for a longer pause on an import ban of the watches.
There's more bad news for Apple this January.